Filed: 8/11/2023ACC: 0001609251-23-000004
📋 What this filing means
KRENSAVAGE ASSET MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $315.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$315.6K
Total AUM (reported)
7.25M
Total Shares
Allocation by class
COM$315.6K100.0%
Portfolio Concentration
Top 3$137.6K43.6%
4–10$173.4K54.9%
11–25$4.6K1.5%
Top 3 weight
43.6%
Top 10 weight
98.5%
Voting Authority Distribution
Total shares with voting rights: 7.57M
Sole
Full voting authority
7.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
BIOGEN INC
SOLEShares176.83K
TypeSH
Market value$50.4K
15.96%
Sole
177.13K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP
SOLEShares202.72K
TypeSH
Market value$44.7K
14.18%
Sole
202.11K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares59.19K
TypeSH
Market value$42.5K
13.47%
Sole
59.49K
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares2.13M
TypeSH
Market value$40.8K
12.92%
Sole
2.14M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares1.10M
TypeSH
Market value$34.5K
10.94%
Sole
1.40M
Shared
0.00
None
0.00
CARDINAL HEALTH INC
SOLEShares353.71K
TypeSH
Market value$33.5K
10.60%
Sole
353.28K
Shared
0.00
None
0.00
TARO PHARMACEUTICAL INDUS
SOLEShares643.08K
TypeSH
Market value$24.4K
7.73%
Sole
641.91K
Shared
0.00
None
0.00
EMBECTA CORP
SOLEShares1.07M
TypeSH
Market value$23.1K
7.33%
Sole
1.06M
Shared
0.00
None
0.00
ENANTA PHARMACEUTICALS INC
SOLEShares687.61K
TypeSH
Market value$14.7K
4.66%
Sole
603.30K
Shared
0.00
None
0.00
VANDA PHARMACEUTICALS INC
SOLEShares362.95K
TypeSH
Market value$2.4K
0.76%
Sole
361.56K
Shared
0.00
None
0.00
KODIAK SCIENCES INC
SOLEShares344.63K
TypeSH
Market value$2.4K
0.75%
Sole
459.49K
Shared
0.00
None
0.00
EAGLE PHARMACEUTICALS INC
SOLEShares113.44K
TypeSH
Market value$2.2K
0.70%
Sole
113.74K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOGEN INCSOLE | COM | 176.83K | SH | $50.4K 15.96% | 177.13K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORPSOLE | COM | 202.72K | SH | $44.7K 14.18% | 202.11K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 59.19K | SH | $42.5K 13.47% | 59.49K | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 2.13M | SH | $40.8K 12.92% | 2.14M | 0.00 | 0.00 |
ALKERMES PLCSOLE | COM | 1.10M | SH | $34.5K 10.94% | 1.40M | 0.00 | 0.00 |
CARDINAL HEALTH INCSOLE | COM | 353.71K | SH | $33.5K 10.60% | 353.28K | 0.00 | 0.00 |
TARO PHARMACEUTICAL INDUSSOLE | COM | 643.08K | SH | $24.4K 7.73% | 641.91K | 0.00 | 0.00 |
EMBECTA CORPSOLE | COM | 1.07M | SH | $23.1K 7.33% | 1.06M | 0.00 | 0.00 |
ENANTA PHARMACEUTICALS INCSOLE | COM | 687.61K | SH | $14.7K 4.66% | 603.30K | 0.00 | 0.00 |
VANDA PHARMACEUTICALS INCSOLE | COM | 362.95K | SH | $2.4K 0.76% | 361.56K | 0.00 | 0.00 |
KODIAK SCIENCES INCSOLE | COM | 344.63K | SH | $2.4K 0.75% | 459.49K | 0.00 | 0.00 |
EAGLE PHARMACEUTICALS INCSOLE | COM | 113.44K | SH | $2.2K 0.70% | 113.74K | 0.00 | 0.00 |